Sofosbuvir-velpatasvir for 12 weeks is safe and effective in patients undergoing dialysis Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pianko, S
  • Borgia, Sergio
  • Dearden, J
  • Lurie, Y
  • Shafran, S
  • Brown, A
  • Hyland, R
  • Lu, S
  • Markova, S
  • Dvory-Sobol, H
  • Osinusi, A
  • Yoshida, E
  • Calleja, J
  • Gane, E

publication date

  • September 1, 2019